Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ephedrine levulinate
- Development stage
- Preclinical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Administration
- Oral, Intranasal, Topical, Intravenous, Intramuscular, Inhalation
01
Overview
Ephedrine levulinate is a small molecule alkaloid and a salt form of ephedrine, used experimentally as a stimulant in products to treat rhinitis or infections of the sinus, mouth, or throat. Its pharmacological effects are primarily due to its action as an agonist at alpha- and beta-adrenergic receptors and by indirectly causing the release of norepinephrine from sympathetic neurons. This results in increased stimulation of the sympathetic nervous system, leading to vasoconstriction, bronchodilation, increased heart rate and cardiac output, and central nervous system stimulation. Ephedrine derivatives have been used for their decongestant properties as well as for treating hypotension during anesthesia[1][2][3].
- Other names
- ephedrine levulinateL-ephedrine levulinate
02
Targets
ADRB1 (β1)NET (Norepinephrine Transporter)ADRA1A (α1A)
Beyond the preview
Go deeper on ephedrine levulinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ephedrine levulinate.